Skip to main content

Table 3 Histopathological diagnosis, treatments, and outcomes

From: Angiomatoid fibrous histiocytoma: a series of seven cases including genetically confirmed aggressive cases and a literature review

Case No

Diagnosis of NB

Diagnosis of EB

Additional treatment

EWSR1 rearrangement

Recurrence / Metastasis

Outcome

Follow-up (mo.)

1

NA

AFH

WE

NA

−/−

CDF

10

2

NA

myxoid liposarcoma

ray amputation

+

−/−

CDF

5

3

Ewing sarcoma

NA

Chemo + WE

+#

+ / +

NED

18

4

spindle cell tumor

NA

WE

+

−/−

CDF

57

5

myxofibrosarcoma

NA

WE

+

−/−

CDF

61

6

NA

synovial sarcoma

Chemo + WE

+#

+ / +

DOD

55

7

NA

AFH

observation

NA

−/−

CDF

40

  1. NB needle biopsy, EB excisional biopsy, ME marginal excision, WE wide excision, CDF continuous disease free, NED no evidence of disease, DOD died of disease, NA not applicable. #. CREB1 rearrangement was also demonstrated by FISH, using custom CREB1 break-apart probe set (GSP laboratory, Kobe, Japan)